R P Mischak
- Immunology top 10%
- Radiology, Nuclear Medicine and Imaging top 5%
- Oncology
- Molecular Biology
- Biotechnology top 5%
- Co-authors
- Lynn E. S̄pitlerBeatrice Langton-WebsterTiffany ChanLaura K. ShawverL.L. MillerW. Scott HarkonenNancy WedelArchie Khentigan
- Topics
- Toxin Mechanisms and Immunotoxins (7 papers)Transgenic Plants and Applications (5 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)
- Journals
- Annals of the New York Academy of SciencesAntimicrobial Agents and ChemotherapyInfection and Immunity
- Partner nations
- United StatesFrance
In The Last Decade
R P Mischak
12 papers receiving 563 citations
Peers
Comparison fields: 5 of 78
- Immunology 253
- Radiology, Nuclear Medicine and Imaging 237
- Oncology 229
- Molecular Biology 209
- Biotechnology 132
Countries citing papers authored by R P Mischak
This map shows the geographic impact of R P Mischak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R P Mischak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R P Mischak more than expected).
Fields of papers citing papers by R P Mischak
This network shows the impact of papers produced by R P Mischak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R P Mischak. The network helps show where R P Mischak may publish in the future.
Co-authorship network of co-authors of R P Mischak
This figure shows the co-authorship network connecting the top 25 collaborators of R P Mischak. A scholar is included among the top collaborators of R P Mischak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R P Mischak. R P Mischak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 67 | |
| 2 | 13 | |
| 3 | A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines. | 200 |
| 4 | The effects of cyclophosphamide on the toxicity and immunogenicity of ricin A chain immunotoxin in rats. | 4 |
| 5 | Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a phase II trial. | 42 |
| 6 | 8 | |
| 7 | 42 | |
| 8 | 6 | |
| 9 | Toxicity and immunogenicity of monoclonal antimelanoma antibody-ricin A chain immunotoxin in rats. | 32 |
| 10 | Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin. | 167 |
| 11 | 8 | |
| 12 | 16 |
About R P Mischak
R P Mischak is a scholar working on Biotechnology, Immunology and Microbiology, having authored 12 papers that have together received 605 indexed citations. Recurring topics across this work include Toxin Mechanisms and Immunotoxins (7 papers), Transgenic Plants and Applications (5 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Biotechnology (132 citations), Immunology (253 citations) and Radiology, Nuclear Medicine and Imaging (237 citations). R P Mischak has collaborated with scholars based in United States and France. Frequent co-authors include Lynn E. S̄pitler, Beatrice Langton-Webster, Tiffany Chan, Laura K. Shawver, L.L. Miller, W. Scott Harkonen, Nancy Wedel, Archie Khentigan, Maguy Del Rio and N A Brophy. Their work appears in journals such as Annals of the New York Academy of Sciences, Antimicrobial Agents and Chemotherapy and Infection and Immunity.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.